TCTR20130314001进行中（未招募）3 期
Effects of spironolactone in hypokalemic CAPD patients: A Double-blinded placebo Controlled Trial.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 85 Years（—）
- 性别
- All
入选标准
- •1. ESRD patients on CAPD
- •2. history of hypokalemia
排除标准
- •1. history of hyperkalemia
- •2. participation in interventional study in the previous 3 months
研究者
相似试验
进行中（未招募）
1 期
The protective effect of the drug spironolactone on transplanted kidneysEUCTR2011-002243-98-DKDepartment of Nephrology, OUH, Odense, DK170
已完成
2 期
The effect of spironolactone in treatment of heart failureHeart Failure.Congestive heart failureIRCT2015101924597N1Vice chancellor for research of Iran university of medical sciences60
已完成
4 期
The effect of the low-dose spironolactone in post adolescent acne: a randomized, double-blind, placebo-controlled trial.acne vulgaris in women who age from 25ᇁ years oldspironolactonepostadolescent acneTCTR20190417004Faculty of Medicine, Chulalongkorn University62
已完成
不适用
combination therapy trial in COVID-19 patientsCOVID19.COVID-19, virus identifiedU07.1IRCT20201003048904N2Boushehr University of Medical Sciences200
已完成
4 期
The Effects of Spironolactone on Calcineurin Inhibitor Induced NephrotoxicityDisorder Related to Renal TransplantationNCT01602861Odense University Hospital188